The above diagram shows the color scheme of the layout in the main result page. The parent entities and officers are those entities, including individual and legal persons, have significant controls over the company in focus. The offspring entities and appointments are those entities that the company in focus can influence on.

Clicking the links on parent entities or officers, and offspring entities or managed companies will put them in focus and show upstream or downstream connections. In general, ascendant entities can be found by moving toward upstream, and descendant entities are by toward downstream. In this way, progenitor entities such as grandparent companies (parents of parent), sibling companies (children of parent), partner companies (parents of child), and progeny entities such as grandchild companies (children of child) can be found easily.

Parent entities and officers
Active 2
  • 1
    Colligon, Stuart
    Company Director born in June 1970
    Individual (6 offsprings)
    Officer
    2019-12-03 ~ dissolved
    OF - Director → CIF 0
    Mr Stuart Jeffrey Colligon
    Born in June 1970
    Individual (6 offsprings)
    Person with significant control
    2016-04-06 ~ dissolved
    PE - Ownership of shares – 75% or more → CIF 0
    PE - Ownership of voting rights - 75% or more → CIF 0
    PE - Right to appoint or remove directors → CIF 0
  • 2
    2 Martin House, 179-181 North End Road, London, United Kingdom
    Active Corporate (2 parents, 6 offsprings)
    Equity (Company account)
    2 GBP2023-12-31
    Officer
    2017-05-17 ~ dissolved
    OF - Secretary → CIF 0
Ceased 6
  • 1
    Smart, David Lee
    Director born in January 1974
    Individual
    Officer
    2009-03-09 ~ 2019-12-03
    OF - Director → CIF 0
  • 2
    Colligon, Stuart Jeffrey
    Director born in June 1970
    Individual (6 offsprings)
    Officer
    2008-04-14 ~ 2009-03-09
    OF - Director → CIF 0
  • 3
    Bunyan, Jill Margaret Ellen, Dr
    Doctor born in October 1965
    Individual
    Officer
    2008-03-14 ~ 2009-03-09
    OF - Director → CIF 0
  • 4
    6th, Floor, 94-96 Wigmore Street, London
    Dissolved Corporate (1 parent, 13 offsprings)
    Equity (Company account)
    1 GBP2023-12-31
    Officer
    2008-03-14 ~ 2008-03-14
    PE - Director → CIF 0
  • 5
    5th, Floor, 86 Jermyn Street, London, United Kingdom
    Active Corporate (4 parents, 142 offsprings)
    Officer
    2008-03-14 ~ 2017-05-02
    PE - Secretary → CIF 0
  • 6
    TADCO SECRETARIAL SERVICES LTD
    6th, Floor, 94-96 Wigmore Street, London
    Dissolved Corporate (1 parent, 22 offsprings)
    Equity (Company account)
    Retained earnings (accumulated losses)
    230,278 GBP2023-12-31
    Officer
    2008-03-14 ~ 2008-03-14
    PE - Secretary → CIF 0
parent relation
Company in focus

PHARMAKI GENERICS LIMITED

Standard Industrial Classification
82990 - Other Business Support Service Activities N.e.c.
Brief company account
Please be reminded the displayed account data is older than 4 years hence might not reflect current company status.
Turnover/Revenue
431,292 GBP2017-01-01 ~ 2017-12-31
22,585 GBP2016-01-01 ~ 2016-12-31
Cost of Sales
-393,237 GBP2017-01-01 ~ 2017-12-31
Gross Profit/Loss
38,055 GBP2017-01-01 ~ 2017-12-31
22,585 GBP2016-01-01 ~ 2016-12-31
Administrative Expenses
-12,966 GBP2017-01-01 ~ 2017-12-31
-8,280 GBP2016-01-01 ~ 2016-12-31
Operating Profit/Loss
25,089 GBP2017-01-01 ~ 2017-12-31
14,305 GBP2016-01-01 ~ 2016-12-31
Interest Payable/Similar Charges (Finance Costs)
-19 GBP2017-01-01 ~ 2017-12-31
Profit/Loss on Ordinary Activities Before Tax
25,070 GBP2017-01-01 ~ 2017-12-31
14,305 GBP2016-01-01 ~ 2016-12-31
Tax/Tax Credit on Profit or Loss on Ordinary Activities
-4,825 GBP2017-01-01 ~ 2017-12-31
-2,861 GBP2016-01-01 ~ 2016-12-31
Profit/Loss
20,245 GBP2017-01-01 ~ 2017-12-31
11,444 GBP2016-01-01 ~ 2016-12-31
Debtors
19,385 GBP2017-12-31
15,021 GBP2016-12-31
Cash at bank and in hand
94,257 GBP2017-12-31
Current Assets
113,642 GBP2017-12-31
15,021 GBP2016-12-31
Net Current Assets/Liabilities
17,205 GBP2017-12-31
11,460 GBP2016-12-31
Net Assets/Liabilities
17,205 GBP2017-12-31
11,460 GBP2016-12-31
Equity
Called up share capital
1 GBP2017-12-31
1 GBP2016-12-31
1 GBP2015-12-31
Retained earnings (accumulated losses)
17,204 GBP2017-12-31
11,459 GBP2016-12-31
11,015 GBP2015-12-31
Equity
17,205 GBP2017-12-31
11,460 GBP2016-12-31
11,016 GBP2015-12-31
Dividends Paid
-14,500 GBP2017-01-01 ~ 2017-12-31
-11,000 GBP2016-01-01 ~ 2016-12-31
Profit/Loss
Retained earnings (accumulated losses)
20,245 GBP2017-01-01 ~ 2017-12-31
Trade Debtors/Trade Receivables
14,831 GBP2017-12-31
15,021 GBP2016-12-31
Other Debtors
1,471 GBP2017-12-31
Trade Creditors/Trade Payables
Amounts falling due within one year
66,512 GBP2017-12-31
Corporation Tax Payable
Amounts falling due within one year
4,825 GBP2017-12-31
2,861 GBP2016-12-31
Other Creditors
Amounts falling due within one year
25,100 GBP2017-12-31
700 GBP2016-12-31
  • PHARMAKI GENERICS LIMITED
    Info
    Registered number 06535118
    53 Rodney Street, Liverpool L1 9ER
    Private Limited Company incorporated on 2008-03-14 and dissolved on 2021-10-26 (13 years 7 months). The company status is Dissolved.
    CIF 0
child relation
Offspring entities and appointments
Active 0
  • Not found in our database.

qrcode

Privacy notice

Terms and conditions

© 2022-2025 Polylogarithmic Technology Ltd. All rights reserved.
Contains public sector information retrieved at 24 April 2025 and licensed under the Open Government Licence v3.0.